Factors Influencing the Attitudes of Chinese Cancer Patients and Their Families Toward the Disclosure of a Cancer Diagnosis
Wenwen Sun(Shandong First Medical University), Minmin Li(Shandong Tumor Hospital), Zhehai Wang(Shandong Tumor Hospital), Shu Fang(Peking University)
Cited by 20
Related Papers
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
|Journal of Clinical Oncology|2016|1k
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|508
Adaptive genic evolution in the <i>Drosophila</i> genomes
|Proceedings of the National Academy of Sciences|2007|227